Rodloff A C, Becker J, Blanchard D K, Klein T W, Hahn H, Friedman H
Infect Immun. 1986 May;52(2):488-92. doi: 10.1128/iai.52.2.488-492.1986.
A number of investigators have provided experimental evidence for synergistic effects in mixed infections with Escherichia coli and Bacteroides fragilis. In vitro studies have suggested that competition for serum opsonins and diminished subsequent phagocytosis by polymorphonuclear leukocytes might explain these effects. In the present study we evaluated the effect of B. fragilis on macrophage phagocytosis. It was shown that peritoneal macrophages from mice injected intravenously 6 to 12 h earlier with 10(8) CFU of encapsulated B. fragilis were markedly suppressed in their phagocytic ability. Injections of laboratory-passaged, less-encapsulated B. fragilis, other bacteria, or latex particles were either not suppressive of macrophage phagocytosis or less effective. When peritoneal macrophages were treated in vitro for 24 h with the same challenge organisms prior to assessing their phagocytic capacity, encapsulated B. fragilis also proved significantly more suppressive than challenges with other organisms or latex particles. We conclude that suppression of macrophage phagocytosis by B. fragilis seems to be an important mechanism contributing to synergistic effects described for mixed aerobic and anaerobic infections.
许多研究人员已提供了大肠杆菌与脆弱拟杆菌混合感染时协同作用的实验证据。体外研究表明,对血清调理素的竞争以及随后多形核白细胞吞噬作用的减弱可能解释了这些效应。在本研究中,我们评估了脆弱拟杆菌对巨噬细胞吞噬作用的影响。结果显示,在6至12小时前经静脉注射10⁸CFU荚膜型脆弱拟杆菌的小鼠的腹腔巨噬细胞,其吞噬能力受到显著抑制。注射实验室传代的、荚膜较少的脆弱拟杆菌、其他细菌或乳胶颗粒,要么对巨噬细胞吞噬作用无抑制作用,要么效果较差。在评估腹腔巨噬细胞吞噬能力之前,若先用相同的激发微生物在体外处理24小时,荚膜型脆弱拟杆菌的抑制作用也明显强于其他微生物或乳胶颗粒激发的情况。我们得出结论,脆弱拟杆菌对巨噬细胞吞噬作用的抑制似乎是导致需氧菌与厌氧菌混合感染协同效应的一个重要机制。